Integrin(整合素)
Intergrin is a cell adhesion receptor for extracellular matrix protein binding. It is also involved in cell to cell interaction and triggers a variety of signaling pathways for cell proliferation, survival and mobility etc.
- Cat.No. 产品名称 Information
-
GC67708
PLN-1474
-
GC65909
Bexotegrast
-
GC65597
Abciximab
-
GC65455
c(phg-isoDGR-(NMe)k)
-
GC64932
αvβ5 integrin-IN-1
-
GC64571
Sibrafiban
-
GC64212
Valategrast hydrochloride
-
GC63490
Valategrast
-
GC62872
BMS-587101
-
GC62566
αvβ1 integrin-IN-1 TFA
-
GC62397
RO0270608
-
GC62380
αvβ1 integrin-IN-1
-
GC62182
Echistatin TFA
-
GC62143
Carotegrast methyl
-
GC61613
Integrin modulator 1
-
GC61520
Cilengitide TFA
An integrin αVβ3 receptor antagonist
-
GC61323
Tetrac
-
GC61109
Natalizumab
-
GC60200
ILK-IN-3
ILK-IN-3 is an integrin linked kinase (ILK) inhibitor with antitumor activity.
-
GC60117
Cyclo(-RGDfK) TFA
An inhibitor of αvβ3 integrin
-
GC60077
BIO5192 hydrate
-
GC50642
LDV
LDV 是一种三肽,是 LDV-FITC 的非荧光类似物。
-
GC50325
BOP
BOP 是一种有效和选择性的双重 α9β1/α4β1 整合素抑制剂,Kd 值在皮摩尔范围内。
-
GC50078
BIRT 377
BIRT 377 是一种有效的口服生物利用度抑制剂,可抑制细胞间粘附分子-1 (ICAM-1) 和淋巴细胞功能相关抗原-1 (LFA-1) 之间的相互作用,Ki 为 25.8 nM。
-
GC50075
BTT 3033
BTT 3033 是一种口服活性的 α2β1 (EC50: 130 nM) 构象选择性抑制剂,通过与 α2I 结构域结合。
-
GC38893
BMS-688521
-
GC38873
α2β1 Integrin Ligand Peptide TFA
-
GC38801
Irigenin
An isoflavonoid with diverse biological activities
-
GC38128
c(phg-isoD-G-R-(NMe)k) TFA
-
GA21306
Cyclo(-Arg-Gly-Asp-D-Tyr-Lys)
c(RGDyK) has been radioiodinated or modified with chelators for use as radiopharmaceutical.
-
GC37975
α2β1 Integrin Ligand Peptide
-
GC37962
Zaurategrast ethyl ester sulfate
-
GC37961
Zaurategrast ethyl ester
-
GC37960
Zaurategrast
-
GC37818
TR-14035
TR-14035 (SB 683698, MDK-1191) is a a dual alpha4beta (α4β) integrin antagonist with IC50 of 7 nM and 87 nM for alpha4beta7 (α4β7) and alpha4beta1 (α4β1), respectively.
-
GC37541
Risuteganib
An anti-integrin peptide
-
GC37524
RGD peptide (GRGDNP) TFA
An inhibitor of integrin-
ligand interactions -
GC36821
OSU-T315
OSU-T315 (ILK-IN-2) is a potent Integrin-Linked Kinase (ILK) inhibitor with IC50 of 0.6 μM. OSU-T315 induces autophagy and apoptosis, both of which are integral to its antiproliferative activity. OSU-T315 exhibits anti-tumor activity.
-
GC36500
LXW7
-
GC34402
RGD Trifluoroacetate
-
GC34301
ILK-IN-2
An ILK inhibitor
-
GC34265
GRGDSP TFA
-
GC34211
Vedolizumab
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
-
GC34141
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
-
GC34133
ATN-161
An integrin receptor antagonist
-
GC33837
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
An integrin receptor antagonist
-
GC33323
GRGDSP
-
GC32967
Integrin Antagonists 27
-
GC32787
iRGD peptide (c(CRGDKGPDC))
-
GC32562
Fradafiban (BIBU-52)